(RTTNews) - Takeda Pharmaceutical Company Limited (TAK) reported first half net profit to owners of company of 112.4 billion yen, down 40.0% from prior year. Earnings per share was 70.45 yen compared to 117.11 yen. Core operating profit was 639.2 billion yen, down 11.2%. Core EPS was 279 yen compared to 310 yen. For the six-month period ended September 30, 2025, revenue was 2.22 trillion yen, down 6.9% from previous year.
For fiscal year ending March 31, 2026, the company expects: basic earnings per share of 97.14 yen, and revenue of 4.5 trillion yen.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Takeda Pharma H1 Net Profit Declines; Revenue Down 6.9%
Published 1 week ago
Oct 30, 2025 at 9:18 AM
Negative
Auto